Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05683379

AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD

Conditions: Duchenne Muscular Dystrophy

Sex: Male

Ages: 0 Years – 25 Years

Healthy volunteers: No

Enrollment: 200

Sponsor: REGENXBIO Inc.

Location: Rare Disease Research Atlanta Georgia

Summary

This is an observational screening study to evaluate the prevalence of anti-adeno-associated serotype 8 (AAV8) antibodies in participants with Duchenne muscular dystrophy (DMD).

Eligibility Criteria

Inclusion Criteria: * Males at least 0 to \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05683379). StuddyBuddy aggregates publicly available trial information.